Journal profile · Medicine-Oncology
Cancer Research on Prevention and Treatment
ISSN 1000-8578 · China Research on Prevention and Treatment · China
Cancer Research on Prevention and Treatment: fully open access; APC charged, amount not published; review about 36 weeks (community reports); 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Cancer Research on Prevention and Treatment is published by China Research on Prevention and Treatment. By OpenAlex counts of its recent articles, its largest topics are Gastric Cancer Management and Outcomes, Head and Neck Cancer Studies and Cancer-related Molecular Pathways, together about 25.4% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Gastric Cancer Management and OutcomesMedicine10.1%
- Head and Neck Cancer StudiesMedicine7.7%
- Cancer-related Molecular PathwaysMedicine7.6%
- Esophageal Cancer Research and TreatmentMedicine6%
- Lung Cancer Research StudiesMedicine5.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.2%
- Lung Cancer Diagnosis and TreatmentMedicine4.9%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Oncology | Q4 | 393/428 | 8th |
| Cancer Research | Q4 | 223/233 | 4th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.07LetPub ·
- h-index
- 5OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 4,262 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 4 |
| 2025 | 0 | 0 | 17 |
| 2024 | 0 | 0 | 12 |
| 2023 | 0 | 0 | 13 |
| 2022 | 0 | 0 | 23 |
| 2021 | 5 | 5 | 22 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 36 weeksLetPub ·
- Submission to publication (journal-reported)
- about 24 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CNY 7,000 | No | CC BY | |
| OpenAlex | CNY 500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteLicense & copyright
- License & copyright
Creative Commons Attribution 3.0 License Model summary
This work is licensed under a Creative Commons Attribution 3.0 License.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- China Research on Prevention and Treatment
- Country or region
- China
- Language
- Chinese
- ISSN
- 1000-8578
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cancer Research on Prevention and Treatment
How long does peer review take at Cancer Research on Prevention and Treatment?
Authors report an average review time of about 36 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cancer Research on Prevention and Treatment?
According to LetPub and DOAJ records, Cancer Research on Prevention and Treatment is indexed in Scopus and DOAJ.
Is Cancer Research on Prevention and Treatment open access, and what is the APC?
Cancer Research on Prevention and Treatment is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .